Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The STEP-1 trial (Wilding et al., New England Journal of Medicine , 2021) showed that patients who stopped at 1 mg lost an average of 10.9% body weight vs 15.8% at 2.4 mg
Visit our Wight Loss Treatment Plan page to review candidacy pricing and request your consultation.
This remarkable outcome suggests Retatrutide may surpass current treatments like semaglutide and tirzepatide, presenting a bright future for those seeking medical weight loss in Peru, New York
Methods Study design An 8-week randomized, double-blind, placebo-controlled parallel study was conducted at a single center, KGK Synergize Inc., in London, ON, Canada, between January 12, 2015 and June 19, 2015
US$ 20.18
US$ 22.09
US$ 23.46
US$ 22.35
US$ 24.17
US$ 22.41
US$ 20.41
